EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Link of mRNA and rRNA Transcription by PUF60/FIR through TFIIH/P62 as a Novel Therapeutic Target for Cancer

Kouichi Kitamura, Tyuji Hoshino, Atsushi Okabe, Masaki Fukuyo iD, Bahityar Rahmutulla iD, Nobuko Tanaka, Sohei Kobayashi iD, Tomoaki Tanaka iD, Takashi Shida, Mashiro Ueda, Toshinari Minamoto iD, Hisahiro Matsubara und 3 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242417341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Kouichi Kitamura und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Chiba University Hospital, Chiba 260-8677, Japan. Hauptthemen laut MEDLINE: Repressor Proteins, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Science, Sports and Culture of Japan (KAKENHI), AMED (Japan Agency for Medical Research and Development), Chiba Foundation for Health Promotion and Disease Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interaction between mRNA and ribosomal RNA (rRNA) transcription in cancer remains unclear. RNAP I and II possess a common N-terminal tail (NTT), RNA polymerase subunit RPB6, which interacts with P62 of transcription factor (TF) IIH, and is a common target for the link between mRNA and rRNA transcription. The mRNAs and rRNAs affected by FUBP1-interacting repressor (FIR) were assessed via RNA sequencing and qRT-PCR analysis. An FIR, a c-myc transcriptional repressor, and its splicing form FIRΔexon2 were examined to interact with P62. Protein interaction was investigated via isothermal titration calorimetry measurements. FIR was found to contain a highly conserved region homologous to RPB6 that interacts with P62. FIRΔexon2 competed with FIR for P62 binding and coactivated transcription of mRNAs and rRNAs. Low-molecular-weight chemical compounds that bind to FIR and FIRΔexon2 were screened for cancer treatment. A low-molecular-weight chemical, BK697, which interacts with FIRΔexon2, inhibited tumor cell growth with rRNA suppression. In this study, a novel coactivation pathway for cancer-related mRNA and rRNA transcription through TFIIH/P62 by FIRΔexon2 was proposed. Direct evidence in X-ray crystallography is required in further studies to show the conformational difference between FIR and FIRΔexon2 that affects the P62–RBP6 interaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Repressor ProteinsNeoplasmsHumansRNA Splicing FactorsRNA, MessengerAlternative SplicingTranscription Factor TFIIHDNA-Binding ProteinsRNA-Binding Proteins

Stichwörter der Autor:innen

FUBP1-interacting repressor (FIR)RPB6 of RNA polymerase (RNAP)aberrant RNA splicingribosomal RNA (rRNA)transcription factor IIH (TFIIH) P62 PH (pleckstrin homology)

Substanzen

RNA Splicing FactorsRNA, MessengerRepressor ProteinsTranscription Factor TFIIHFUBP1 protein, humanDNA-Binding ProteinsRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Chiba University Hospital, Chiba 260-8677, Japan.
  • Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Department of Molecular Design, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.
  • Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Department of Medical Technology and Sciences, Health and Sciences, International University of Health and Welfare, Chiba 286-8686, Japan.
  • Research Team for Promoting Independence and Mental Health, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo 173-0015, Japan.

ORCID-Profile: Masaki Fukuyo, Bahityar Rahmutulla, Sohei Kobayashi, Tomoaki Tanaka, Toshinari Minamoto, Hideshi Ishii, Kazuyuki Matsushita

Förderung

  • Ministry of Education, Science, Sports and Culture of Japan (KAKENHI)
  • AMED (Japan Agency for Medical Research and Development)
  • Chiba Foundation for Health Promotion and Disease Prevention
  • Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University to K.M.

Zitieren

APA

Kitamura, K., Hoshino, T., Okabe, A., Fukuyo, M., Rahmutulla, B., Tanaka, N., Kobayashi, S., Tanaka, T., Shida, T., Ueda, M., Minamoto, T., Matsubara, H., Kaneda, A., Ishii, H., & Matsushita, K. (2023). The Link of mRNA and rRNA Transcription by PUF60/FIR through TFIIH/P62 as a Novel Therapeutic Target for Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417341

Vancouver

Kitamura K, Hoshino T, Okabe A, Fukuyo M, Rahmutulla B, Tanaka N, et al. The Link of mRNA and rRNA Transcription by PUF60/FIR through TFIIH/P62 as a Novel Therapeutic Target for Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417341

BibTeX
@article{Kitamura2023,
  author = {Kitamura, Kouichi and Hoshino, Tyuji and Okabe, Atsushi and Fukuyo, Masaki and Rahmutulla, Bahityar and Tanaka, Nobuko and Kobayashi, Sohei and Tanaka, Tomoaki and Shida, Takashi and Ueda, Mashiro and Minamoto, Toshinari and Matsubara, Hisahiro and Kaneda, Atsushi and Ishii, Hideshi and Matsushita, Kazuyuki},
  title = {The Link of mRNA and rRNA Transcription by PUF60/FIR through TFIIH/P62 as a Novel Therapeutic Target for Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242417341}
}
Kostenlos starten →